"BAP1损失诱导衰老,并增强对放射治疗和老化药物的反应"
bioRxiv : the preprint server for biology
|February 23, 2026
概括
失去BRCA1关联蛋白1 (BAP1) 驱动肌膜黑色素瘤的衰老,促进瘤的攻击性. 用老化药物准衰老途径可能为BAP1-突变性脑膜黑色素瘤提供新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- BRCA1关联蛋白1 (BAP1) 的非活化突变在皮膜黑色素瘤 (UM) 中很常见,与侵袭性疾病相关.
- BAP1损失在UM瘤攻击性中的确切作用及其潜在机制尚未完全理解.
研究的目的:
- 研究BAP1损失在促进UM细胞衰老中的作用.
- 探索针对BAP1突变UM的衰老途径的治疗潜力.
主要方法:
- 对癌症基因组图谱UM队列在BAP1-突变瘤中衰老途径活性进行分析.
- 在BAP1损失时评估衰老特征 (p16,p21,γH2AX,β-gal) 的功能测试.
- 在BAP1中断后对老化剂 (达沙替尼,奎尔塞丁) 的UM细胞反应的评估,有或没有辐射.
主要成果:
- BAP1突变的UM瘤显示老化通路活性增加和SASP因子升高.
- BAP1损失诱导了关键的衰老标志物,包括上调的p16/p21,增加的β-gal活性和DNA损伤焦点 (γH2AX).
- BAP1 knockdown使UM细胞对老化剂敏感,这种效应由电离辐射强化.
结论:
- 丢失BAP1是细胞衰老的重要驱动因素在毛膜黑色素瘤.
- 用老化药物向衰老是一种对BAP1突变UM的有前途的治疗策略.
更多相关视频
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
25.3K
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
3.6K
相关概念视频
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
DNA Damage can Stall the Cell Cycle
10.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle
3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
